Fast and Secure Delivery Worldwide Express & Expedited Shipping Service
USD $107.74
IndiaRANVELA is an innovative medication designed to manage phosphate levels in patients with chronic kidney disease who are on dialysis. It contains Sevelamer Carbonate, a non-calcium, non-metal phosphate binder that helps to prevent the absorption of dietary phosphate.
RANVELA is primarily used to control hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease. By binding to phosphate in the gastrointestinal tract, it reduces the amount of phosphate absorbed into the bloodstream.
Sevelamer Carbonate works by binding phosphate in the digestive tract, preventing it from being absorbed into the body. This helps maintain healthy phosphate levels, which is crucial for bone health and overall metabolic function.
RANVELA is intended for adults and children over the age of six who have chronic kidney disease and are undergoing dialysis. It is essential to consult a healthcare provider to determine if RANVELA is appropriate for your specific condition.
Common side effects may include gastrointestinal issues such as nausea, vomiting, diarrhea, or constipation. It is important to discuss any side effects with a healthcare professional, especially if they persist or worsen.
RANVELA is typically taken with meals to maximize its effectiveness. Follow the dosage instructions provided by your healthcare provider for optimal results.
RANVELA (Sevelamer Carbonate) is a vital medication for managing phosphate levels in patients with chronic kidney disease. With its unique formulation, it provides an effective solution for those needing phosphate control while minimizing potential side effects.
